Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
4
×
clinical trials
detroit blog main
detroit top stories
eli lilly
fda
4
×
indiana blog main
indiana top stories
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
biogen
cancer
cancer immunotherapy
investing
startups
alzheimer's disease
What
bio
4
×
roundup
biotech
days
drug
fda
growing
news
alliance
alzheimer’s
annual
approved
assessed
attention
august
bristol
busy
buy
calls
changing
color
communities
companies
conference
crispr
decisions
devices
digital
disease
drugs
epidemic
esmo
europe
fatty
frenzied
germany
hosted
hours
investment
known
Language
unset
Current search:
fda
×
biotech
×
bio
×
pfizer
×
" indiana top stories "
×
" bristol-myers squibb "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More